P2B001
Pharma Two B
[]
today we announced that results from the pivotal phase 3 clinical trial evaluating p2b001, an investigational extended release pramipexole
and rasagiline formulation, in people with early-stage
#parkinsonsdisease will be presented at . #aanam 
Pharma Two B is a clinical-stage pharmaceutical company striving to improve patients’ quality of life by developing innovative combination products.